1. Home
  2. SCLX vs LFVN Comparison

SCLX vs LFVN Comparison

Compare SCLX & LFVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$5.69

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

Logo Lifevantage Corporation (Delaware)

LFVN

Lifevantage Corporation (Delaware)

HOLD

Current Price

$5.99

Market Cap

51.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SCLX
LFVN
Founded
2011
N/A
Country
United States
United States
Employees
34
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
48.5M
51.5M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
SCLX
LFVN
Price
$5.69
$5.99
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$11.00
AVG Volume (30 Days)
92.6K
826.6K
Earning Date
04-10-2026
05-06-2026
Dividend Yield
N/A
3.56%
EPS Growth
N/A
226.09
EPS
N/A
0.30
Revenue
N/A
$203,204,000.00
Revenue This Year
$122.52
N/A
Revenue Next Year
$186.30
N/A
P/E Ratio
N/A
$22.03
Revenue Growth
N/A
1.86
52 Week Low
$4.20
$3.90
52 Week High
$34.27
$15.00

Technical Indicators

Market Signals
Indicator
SCLX
LFVN
Relative Strength Index (RSI) 38.04 40.00
Support Level $4.20 $4.86
Resistance Level $7.77 $6.18
Average True Range (ATR) 0.98 1.92
MACD -0.04 -0.35
Stochastic Oscillator 1.38 6.95

Price Performance

Historical Comparison
SCLX
LFVN

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

About LFVN Lifevantage Corporation (Delaware)

Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.

Share on Social Networks: